DFO
ALXN

Duquesne Family Office’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Duquesne Family Office’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-148,000
Closed -$20.6M – 49
2018
Q3 		$20.6M Buy
+148,000
New +$20.6M 0.98% 21